Back to
DRIEHAUS CAPITAL MANAGEMENT LLC
XENE26 quarters
Position history for
DRIEHAUS CAPITAL MANAGEMENT LLC's holdings in XENON PHARMACEUTICALS INC
Yes. Driehaus Capital Management holds 4,418,557 shares of XENE (Xenon Pharmaceuticals), worth $266.7M, as of its Q2 2026 13F filing. It reduced the position by 73,096 shares (-1.6%) from Q1 2026. Driehaus Capital Management has held XENE since Q1 2020, across 26 quarterly 13F filings. XENE is 1.5% of Driehaus Capital Management's reported 13F portfolio.
Current Value
$266.7M
Current Shares
4.4M
Total Value Change
+$261.5M
Total Shares Change
+4M
Quarter-by-Quarter History
Other major holders of XENE: FMR LLC, BlackRock, Inc.